Provided by Tiger Trade Technology Pte. Ltd.

Defiance Leveraged Long + Income HIMS ETF

5.43
0.0000
Volume:- -
Turnover:- -
Market Cap:2.71M
PE:- -
High:5.43
Open:5.43
Low:5.43
Close:5.43
52wk High:28.09
52wk Low:4.63
Shares:500.00K
Float Shares:500.00K
Volume Ratio:- -
T/O Rate:- -
Dividend:5.56
Dividend Rate:102.40%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Hims & Hers Health, Inc. : Citigroup Cuts Target Price to $33 from $35

THOMSON REUTERS
·
Aug 11

Morgan Stanley Adjusts PT on Hims & Hers Health to $28 From $21, Maintains Equalweight Rating

MT Newswires Live
·
Aug 11

Dow Jones Top Company Headlines at 5 am ET: Intel Increases Size of Stock Offering to Raise $20 Billion | Samsung ...

Dow Jones
·
Aug 11

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Lifestance Health Group (LFST) and DaVita (DVA)

TIPRANKS
·
Aug 11

Hims & Hers Health Falls After Bigger-than-Expected Q2 Loss

Reuters
·
Aug 11

Hims & Hers Health Shares Down 7.3% Premarket After Co Posts Wider-than-Expected Q2 Loss

THOMSON REUTERS
·
Aug 11

Premarket Movers | Riot Platforms Surges 23%; Plug Power Gains 9%; HIMS Falls 7%; USA Rare Earth, Rocket Lab Drop 8% Each

Tiger Newspress
·
Aug 11

Dow Jones Top Company Headlines at 9 PM ET: South Korea's Hanwha Makes $1 Billion Push into U.S. Naval Shipbuilding | Nvidia, ...

Dow Jones
·
Aug 11

24H | Riot Platforms Jumps 25%; SMCI Climbs 1%; USA Rare Earth Tumbles 8%; Rocket Lab USA Drops 7%

US Overnight
·
Aug 11

Stocks to Watch: Hims & Hers, Rocket Lab, Plug Power, Babcock & Wilcox

Dow Jones
·
Aug 11

Hims & Hers Says Testosterone Outpacing All Drugs Other than Weight-Loss

Dow Jones
·
Aug 11

Hims & Hers Gets 17-Fold Explosion in Overseas Business

Dow Jones
·
Aug 11

Hims & Hers Health Testing Peptide Ingredients Ahead of Expected FDA Decision on Allowing Compounding for the Drugs - Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Expects Gross Margins to Remain Below Historical Levels, Due to International, Weight-Loss Business Expansion - Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Exec Says AI Technology to Lower Prices for Weight-Loss Subscribers in 2026- Conf Call

THOMSON REUTERS
·
Aug 11

Hims & Hers Says Co in Process of Testing Bpc-157 Peptide- Conf Call

THOMSON REUTERS
·
Aug 11

Hims Stock Falls on Earnings. Why a Guidance Hike Isn't Enough.

Dow Jones
·
Aug 11

Hims & Hers Able to Scale Peptide Offering if US Law Allows, CFO Says

Reuters
·
Aug 11

Hims & Hers Health, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Hims & Hers Health: International Operations, Weight-Loss Products Produced Lower Profit Margins for Hims in Second Quarter, CFO Says

THOMSON REUTERS
·
Aug 11